ARMS2 Gene Variants and Their Impact on Vision in Eye Diseases
Author Information
Author(s): Bessho Hiroaki, Honda Shigeru, Kondo Naoshi, Negi Akira
Primary Institution: Kobe University Graduate School of Medicine
Hypothesis
The study investigates the association of ARMS2 gene polymorphisms with the phenotype of typical neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.
Conclusion
ARMS2 variants are likely associated with the phenotype and the effects of photodynamic therapy in tAMD and PCV.
Supporting Evidence
- Patients with a G allele had significantly better vision at 3 months after PDT.
- tAMD patients with a TT genotype had significantly poorer vision at 12 months after PDT.
- The additive model of the G allele at rs10490924 was associated with significantly better BCVA at 12 months after PDT.
Takeaway
This study looked at how certain genes affect vision in patients with eye diseases and found that some gene variations can lead to better or worse vision after treatment.
Methodology
The study genotyped SNPs at rs10490924 in 68 tAMD and 119 PCV patients who underwent photodynamic therapy, comparing visual acuity and lesion size among genotypes.
Limitations
The study has a relatively smaller sample size and is retrospective in nature.
Participant Demographics
Participants included 68 tAMD patients (mean age 76 years, 53 men and 15 women) and 119 PCV patients (mean age 73 years, 96 men and 23 women), all Japanese.
Statistical Information
P-Value
0.0095
Confidence Interval
0.027–0.19
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website